Continuous hyperfractionated accelerated radiotherapy (CHART) using volumetric modulated arc therapy (VMAT) for locally advanced non-small cell lung cancer (NSCLC) - the clinical experience

被引:1
作者
Shrimali, R. [1 ]
Sen, P. [1 ]
Arunsingh, M. [1 ]
Mahata, A. [2 ]
Mallick, I. [1 ]
Prasath, S. [2 ]
Achari, R. [1 ]
Chatterjee, S. [1 ]
机构
[1] Tata Med Ctr, Radiat Oncol, Kolkata, India
[2] Tata Med Ctr, Kolkata, India
关键词
D O I
10.1016/S0169-5002(16)30138-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
121
引用
收藏
页码:S43 / S44
页数:2
相关论文
共 50 条
  • [21] Continuous hyperfractionated accelerated radiotherapy (CHART) in non small cell lung cancer: A single centre experience as standard treatment
    Hatton, M
    Omar, D
    Fisher, P
    Peter, P
    Mohanamurali, K
    LUNG CANCER, 2005, 49 : S307 - S307
  • [22] Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer
    Haslett, Kate
    Poettgen, Christoph
    Stuschke, Martin
    Faivre-Finn, Corinne
    JOURNAL OF THORACIC DISEASE, 2014, 6 (04) : 328 - 335
  • [23] Clinical Outcome of Hybrid-Volumetric Arc Therapy (H-VMAT) for Advanced Inoperable Non-Small Cell Lung Cancer (NSCLC)
    Chan, Oscar S. H.
    Hung, Albert W. M.
    Chang, Amy T. Y.
    Chan, Lucy L. K.
    Chan, Connie C. C.
    Yeung, R. M. W.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S447 - S448
  • [24] Survival following treatment of non-small cell lung cancer (NSCLC) using continuous hyperfractionated accelerated radiotherapy (CHART): A single-centre retrospective analysis
    Ayre, G.
    Casswell, G.
    Comins, C.
    Falk, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S108 - S109
  • [25] Sparing Functional Lung Using Optimized Volumetric Modulated Arc Therapy in Thoracic Radiation for Locally Advanced Non-Small Cell Lung Cancer
    Westergaard, S. A.
    Castillo, R.
    Rupji, M.
    Bell, J.
    Castro, R.
    Harms, J.
    Kayode, O.
    Nguyen, T.
    Wolf, J.
    Higgins, K. A.
    Bradley, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E456 - E457
  • [26] Clinical observation after combined pulmonary Stereotactic Radiotherapy (SBRT) and mediastinal conventionally fractionated Volumetric Arc Therapy (VMAT) in advanced Non-Small Cell Lung Cancer (NSCLC)
    Stuewe, Cedric
    Eichkorn, Tanja
    Tonndorf-Martini, Eric
    Schubert, Kai
    Regnery, Sebastian
    Held, Thomas
    Bozorgmehr, Farastuk
    Christopoulos, Petros
    Koenig, Laila
    Naumann, Patrick
    Adeberg, Sebastian
    Herfarth, Klaus
    Thomas, Michael
    Rieken, Stefan
    Debus, Juergen Peter
    El Shafie, Rami A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 147 - 147
  • [27] PROSPECTIVE DATA OF CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) FOR NON-SMALL CELL LUNG CANCER (NSCLC): CLINICAL OUTCOME AND PATIENT SATISFACTION SURVEY OF THE NORTHERN REGIONAL CANCER CENTRE
    Loo, H. W.
    Klapper, R.
    Mulvenna, P.
    McMenemin, R.
    McDonald, F.
    Atherton, P.
    Mazdai, G.
    THORAX, 2009, 64 : A83 - A83
  • [28] Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial
    Chen, GY
    Jiang, GL
    Qian, H
    Wang, LJ
    Yang, HJ
    Fu, XL
    Wu, KL
    Zang, Z
    Zhao, S
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 (02) : 157 - 162
  • [29] A Comparison of Outcomes of Intensity Modulated Radiotherapy and Volumetric Arc Therapy in Non-Small Cell Lung Cancer
    Conway, Ellie
    Young, Linda
    Black, Sarah-Louis
    Nelson, Catherine
    Tumelty, Karen
    Crockett, Cathry
    O'Hare, Jolyne
    Hanna, Gerard G.
    Mcgarry, Conor K.
    Mcaleese, Jonathan
    Walls, Gerard M.
    LUNG CANCER, 2025, 200
  • [30] Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer: Pooled results from 5 UK centres
    Din, O.
    Hatton, M.
    Cameron, A.
    Lester, J.
    Moore, B.
    Erridge, S.
    Ironside, J.
    Warnock, J.
    Gee, A.
    Falk, S.
    Klinsman, J.
    Morgan, S.
    Worvill, J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S192 - S192